Aristotle University Of Thessaloniki (AUTH)
Συμβολή της εργαστηριακής διερεύνησης και της μελέτης του γονιδιακού πολυμορφισμού των Fcγ υποδοχέων IIa και IIIa στην ιδιοπαθή άνοση θρομβοπενία των παιδιών
Abstract
dc:descriptionThe aim of the present study is to primarily investigate the role of FcγRIIA – 131H/R and FcγRIIIA – 158V/F polymorphisms in the pathogenesis of childhood primary immune thrombocytopenia (ITP), disease natural course and the therapeutic result of intravenous immunoglobulin (IVIG) administration. Additionally, we investigate risk factors for chronicity and conduct a comparative study between IVIG and IV anti-D administration in newly-diagnosed childhood ITP. Lastly, one of the aims is to study the role of cytokines representing T – lymphocytes’ subgroups (IL-2, IL-4, IL-17 and TGF-b1). Patients and methods: Fifty three children were enrolled in this study (26 male and 27 female, mean age: 5,95 ± 3,88 years), 30 with newly-diagnosed, 2 with persistent and 21 with chronic ITP. The genotypic polymorphisms of FcγRIIA – 131 H/R and FcγRIIIA – 158V/F were identified in all patients, as well as 45 adult healthy controls. Data such as age, platelet number, duration of symptoms and bleeding stage at diagnosis were evaluated in all patients in association to chronicity. IVIG was administered to 23 children with newly-diagnosed ITP at a dose of 0.8 – 1g/kg, whereas 10 children received 50 mcg/kg of IV anti-D. Data that were evaluated included: platelet rise at 24, 48, 72 hours and 7 days post infusion, as well as the percentage of children that reached a platelet count > 20000/μL at 24 hours post infusion, with regards to the bleeding stage at presentation. Eventually, cytokines IL-2, IL-4, IL-17 and TGF-b1 were measured in 19 children with newly-diagnosed and chronic ITP before treatment, as well as 20 controls matched for age and sex. Results: Genotype – 158VF and high affinity allele V (valine) of FcγRIIIA is overrepresented in patients with ITP when compared to controls. Neither of the two Fcγ receptor single nucleotide polymorphisms seems to have any impact on chronicity or therapeutic effect of IVIG. Analysis of the rest of the patients’ data showed that duration of hemorrhagic symptoms > 14 days at diagnosis is a strong prognostic factor for chronicity in childhood ITP. With regards to comparing treatment modalities (IVIG and IV anti-D) in children with newly-diagnosed ITP, there was no statistically significant difference in platelet rise at any time post infusion between the two groups, while it was proven that children presenting with mucosal bleeding did not respond well to treatment with IVIG. Eventually, we found statistically significant higher levels of IL-4 (Th2 response) and TGF-b1 (T – regulatory lymphocytes) in patients with active immune thrombocytopenia in contrast to controls. Concluding, it seems that FcγRIIIa – 158V/F polymorphism contributes to the pathogenesis of ITP, namely in disease susceptibility, the duration of hemorrhagic symptoms > 14 days at diagnosis is a prognostic factor for chronicity, IVIG and IV anti-D are equally effective in childhood newly-diagnosed ITP, while mucosal bleeding at diagnosis is a poor prognostic factor to response to IVIG. Eventually, it seems that disease activity is related to high levels of IL-4 and TGF-b1.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papagianni, Andromachi
- Παπαγιάννη, Ανδρομάχη
Subjects
dc:subject × 18- Ιδιοπαθής άνοση θρομβοπενία
- Ιδιοπαθής θρομβοπενική πορφύρα
- Fcγ υποδοχέας IIa και IIIa
- Πολυμορφισμοί
- Παιδιά
- Παιδική ηλικία
- ΙΘΠ
- Primary immune thrombocytopenia
- Idiopathic thrombocytopenic purpura
- FcγR IIa and IIIa
- Polymorphisms
- Children
- Childhood
- ITP
- Επιστήμες Μηχανικού και Τεχνολογία
- Βιοϊατρική Μηχανική
- Engineering and Technology
- Medical Engineering
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27624